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 ABSTRACT Ceramidases catalyze the conversion of ceramide to sphingosine. They are 
acylaminohydrolases that catalyze the deacylation of the amide-linked saturated fatty acid 
from ceramide to generate sphingosine. They also catalyze the reverse reaction of ceramide 
biosynthesis using sphingosine and fatty acid. In mammals, different proteins catalyze these 
reactions while individually exhibiting optimal activity over a narrow pH range and have been 
accordingly called acid, neutral, and alkaline ceramidases. Several genes encode for variants 
of alkaline ceramidase in mammals.  Brainwashing ( Bwa ) is the only putative alkaline cerami-
dase homologue present in  Drosophila . In this study we have demonstrated that BWA does 
not exhibit ceramidase activity and that  bwa null mutants display no loss of ceramidase activ-
ity. Instead, the neutral ceramidase gene  CDase encodes the protein that is responsible for 
all measurable ceramidase activity in  Drosophila . Our studies show strong genetic interaction 
of  Bwa with  CDase and the  Drosophila ceramide kinase gene ( DCERK ). We show that, al-
though BWA is unlikely to be a ceramidase, it is a regulator of sphingolipid fl ux in  Drosophila . 
 Bwa exhibits strong genetic interaction with other genes coding for ceramide-metabolizing 
enzymes. This interaction might partly explain its original identifi cation as a ceramidase. 
 INTRODUCTION 
 Most sphingolipids exist as integral components of membranes. 
Several of them are found to exist in monomeric forms within the 
cytosolic milieu and in the circulatory system. Membrane sphingo-
lipids, especially those found at the cell surface, can act as antigenic 
determinants, cell–cell interaction molecules, essential components 
of glycolipid calyx surrounding the cells, and structural determinants 
of plasma membrane and perform a wide spectrum of other func-
tions ( Karlsson  et al. , 1968 ;  Merrill  et al. , 1997 ; Shayman,  2000 ). It is 
believed that several of the sphingolipids are generated within the 
membrane milieu as second messengers in response to cellular 
stimuli ( Spiegel  et al. , 1996 ; Spiegel and Merrill,  1996 ). Therefore it 
is not surprising that they have been implicated in a wide array of 
events ranging from cellular apoptosis to cell division and differen-
tiation. Sphingolipids are hydrophobic compounds derived from 
the aliphatic amino alcohol sphingosine. Sphingosines are  N-
acylated to generate ceramides ( Merrill  et al. , 2001 ). In most eukary-
otes, the  de novo synthesis of sphingolipids begins with the con-
densation of serine and a fatty acyl coenzyme A  in the endoplasmic 
reticulum (ER). Reactions leading up to the biosynthesis of ceramide 
occur in the ER, after which the ceramide is translocated to the Golgi 
complex, a process that is thought to be mediated mostly by the 
action of ceramide transfer protein (van Meer and Holthuis,  2000 ; 
 Hanada  et al. , 2003 ; Hanada,  2006 ). The transfer of ceramide to the 
Golgi complex ensures the subsequent modifi cation of ceramide 
at the 2-OH position that results in the generation of complex 
sphingolipids. Most of the enzymes required for the generation of 
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complex sphingolipids are localized to the post-ER compartments. 
The variation in the chain length of fatty acids (of sphingosine), 
n-acylated fatty acids in ceramide, and various substitutions at 
the 2-OH position are responsible for the existence of more than 
300 species of sphingolipids in a mammalian organism ( Hannun 
 et al. , 2001 ). 
 Ceramide is a central component in the sphingolipid metabolic 
pathway (Hannun and Obeid,  2008 ). It is a key intermediate in the 
 de novo biosynthetic pathway, fi rst generated in the ER and then 
transferred to the Golgi complex. Upon its transfer, it is further me-
tabolized in one of many different biosynthetic pathways. It acts as 
a substrate in the biosynthesis of sphingomyelin, sphingosine and 
sphingosine 1-phosphate, ceramide 1-phosphate, and a series of 
glycosphingolipids with increasingly complex carbohydrate substi-
tution at the 2-OH position. It is also an important intermediate in 
the sphingolipid catabolic pathway. Thus ceramide fulfi lls the role 
of a branch point intermediate that could be rerouted through one 
of several possible metabolic routes. Therefore ceramide can be 
considered a key component of several regulatory circuits and cy-
cles, such as the sphingomyelin cycle proposed to be operative in 
the sphingolipid metabolic pathway ( Holthuis  et al. , 2001 ; Hannun 
and Obeid,  2008 ). Among the enzymes that act on ceramide are 
sphingomyelin synthases, ceramidases, ceramide kinases, and glu-
cosylceramide synthase, which lead to the generation of sphingo-
myelin, sphingosine, ceramide 1-phosphate, and glucosylceramides, 
respectively. Ceramide is also a product in the reaction catalyzed by 
sphingomyelinases, glucocerebrosidase, 
and so forth. Ceramidases are a class of n-
acyl fatty acyl hydrolases that generate fatty 
acid and sphingosine from ceramide. They 
are variously classifi ed as acid, neutral, or 
alkaline ceramidases based on their pH op-
timum for the ceramidase activity. It is now 
generally believed that these activities are 
encoded by separate enzymes (Mao and 
Obeid,  2008 ). 
 Drosophila encodes for a neutral ce-
ramidase homologue, called CDase 
( Acharya  et al. , 2003 , 2004;  Rohrbough 
 et al. , 2004 ; Acharya and Acharya,  2005 ; 
 Acharya  et al. , 2008 ). Using a viable null 
mutant of  Drosophila CDase we now 
demonstrate that it accounts for all mea-
surable ceramidase activity in the fl y. 
We generated deletion mutants of 
 Brainwashing ( Bwa ), the putative alkaline 
ceramidase homologue, and showed that 
these mutants exhibit no loss in cerami-
dase activity. Using genetic epistasis 
experiments and mass spectrometric 
analysis of sphingolipid metabolites, we 
show that BWA protein regulates sphin-
golipid fl ux and affects ceramide concen-
trations in the animal without functioning 
as a ceramidase. 
 RESULTS 
 CDase null mutations have no residual 
ceramidase activity at neutral pH 
 Recently we reported the generation and 
characterization of a null mutant of  Droso-
phila ceramidase,  cdase 1 (Acharya et al., 
 2008 ). These fl ies were generated by ethyl methanesulfonate 
(EMS) mutagenesis and harbor a termination codon at amino acid 
641 of the  CDase gene. The resulting premature termination led 
to an extremely unstable protein as examined by Western analysis, 
and the  cdase 1 fl ies are CDase null mutants. The mutant fl ies were 
homozygous embryonic lethal (or lethal over a defi ciency that un-
covers the  CDase genomic region as show in  Figure 1A ) and are 
rescued by the introduction of a transgene. The presence of a 
closely linked suppressor mutation on the same chromosome, 
however, allowed us to recover viable null mutants over the defi -
ciency (suppressor  cdase 1 or viable null  cdase 1 ) ( Figure 1A ). The 
identity of this viable suppressor mutation remains unknown. 
Although the viable null  cdase 1 fl ies demonstrated specifi c 
phototransduction defects, they were not only viable but also fer-
tile. The availability of adult fertile viable null CDase mutants en-
abled us to further explore the ceramidase function in  Drosophila . 
Tissue extracts derived from viable null  cdase 1 mutants demon-
strated no residual ceramidase activity at pH 7.0 as described pre-
viously ( Figure 1B ) ( Acharya  et al. , 2008 ). The control  w 1118 had a 
specifi c activity of 0.43 nmol·min−1·mg−1 protein. The enzymatic 
activity was restored by the introduction of a genomic copy of the 
 CDase gene into these mutant fl ies ( Acharya  et al. , 2008 ). After 
confi rming the lack of neutral ceramidase activity in the  cdase 1 vi-
able null fl ies, we decided to undertake biochemical and genetic 
studies to investigate the presence of other ceramidases and 
probe the genetic interactions of CDase in  Drosophila . 
 FIGURE 1:  CDase is the major ceramidase active in the pH range 5.0–11.0. (A) A viable null allele 
of  cdase 1 was obtained by the presence of suppressor mutation that enabled the recovery of the 
lethal  cdase 1 over a defi ciency that uncovers the  CDase gene region. (B) The viable null allele of 
 cdase 1 displays no ceramidase activity. (C) The viable null mutant displays no ceramidase activity 
in the pH range 5.0–11.0, whereas the wild-type control  w 1118 demonstrates robust ceramidase 
activity in that pH range.  cdase 1 in (B) and (C) refers to the viable null mutant. All activity 
measurements are an average of at least six measurements, and the error bars denote SD. 
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to zero at approximately pH 12.0 ( Figure 1C ). Viable null  cdase 1 
mutants, in contrast, showed no enzymatic activity at any of the pH 
values measured. Also, introduction of two copies of the CDase 
transgene restored the activity back to the levels observed in  w 1118 
extracts. We have in the past confi rmed this activity by overexpress-
ing CDase protein using the Upstream Activating Sequence (UAS)-
Gal4 system and driving the expression of CDase using a photo-
receptor-specifi c Gal4 promoter ( Acharya  et al. , 2003 ). In that study, 
head extracts were used for the biochemical assays. Also, 
overexpression of CDase showed increased activity across the whole 
spectrum of pH from 5.0 to 11.0 (unpublished data ). These studies 
suggest that CDase is the major contributor of biochemical cerami-
dase activity in  Drosophila . 
 This was a surprising fi nding because other organisms have more 
than one protein catalyzing this activity ( Hannun  et al. , 2001 ). Our 
results, however, indicate that, in  Drosophila, CDase protein shows 
enzyme activity over a broad pH range, and the results from viable 
null  cdase 1 mutants indicates that CDase contributes to most of the 
observable ceramidase activity.  Drosophila does not encode for an 
acid ceramidase homologue ( Yoshimura  et al. , 2002 ; Acharya and 
Acharya,  2005 ), and a sequence homology search indicated the 
presence of  Bwa as a  Drosophila alkaline ceramidase homologue 
( Boquet  et al. , 2000 ; Acharya and Acharya,  2005 ).  Bwa was initially 
identifi ed as a gene the protein product of which was thought to be 
involved in the separation of the two hemispheres of the  Drosophila 
brain. A P-element insertion in the intron of this gene was reported 
 CDase accounts for all observable ceramidase activity 
in Drosophila 
 Previous studies measuring ceramidase activity in mammalian tis-
sues and tissue culture cells have confi rmed the presence of bio-
chemical activity across a wide range of pH values, and the activities 
at acid and alkaline pH were concluded to be a combined contribu-
tion of several ceramidases, each of which demonstrated an opti-
mum enzymatic activity over a narrow pH range (Hassler and Bell, 
 1993 ;  Merrill  et al. , 1997 ;  van Echten-Deckert  et al. 1997 ; Luberto 
and Hannun,  1999 ). For example, acid ceramidase protein has an 
optimal pH of ∼4.5 ( Li  et al. , 1999 ). Alkaline ceramidases demon-
strate maximum activity at approximately pH 8.0. Neutral cerami-
dases (CDase and its homologues) were shown to be active in the 
neutral pH range. We explored the presence of additional cerami-
dases that could contribute to the enzymatic activity in  Drosophila, 
then assessed ceramidase activity in tissue extracts from control 
 w 1118 and viable null  cdase 1 mutants prepared in appropriate buf-
fers, the pH values of which ranged from pH 5.0 to pH 11.0. We 
measured in control  w 1118 extracts for total enzymatic activity ( Figure 
1B ). We used the viable null  cdase 1 mutant extracts to measure ac-
tivity of other ceramidases that could contribute to the enzymatic 
activity under the experimental conditions.  w 1118 extracts showed 
activity across a broad range of pH. Whereas there was minimal ac-
tivity at pH 4.0, 50% of peak activity was observed at pH 5.0, and 
activity reached a maximum at approximately pH 8.0. Comparable 
enzymatic activity was observed even at pH 11.0 before tapering off 
 FIGURE 2:  Generation of deletion null mutants of  Bwa , the putative alkaline ceramidase homologue in  Drosophila . 
(A)  Bwa is the alkaline ceramidase homologue in  Drosophila with closest homology to mammalian alkaline ceramidase 1. 
(B) A diagram demonstrating the extent of genome deletion in the  bwa 1 and  bwa 2 null mutants generated by mobilizing 
the P-element insertion in the second intron of the gene. (C) Left panel – Genomic PCR of the two deletion mutants 
generated by mobilizing a P-element. RT-PCR analysis confi rms the deletion of two exons in the messenger RNA 
(mRNA) of the mutant fl ies resulting in truncated mRNA products. 
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observed between the two mutant hemispheres in both the alleles, 
confi rming that  Bwa gene product is not involved in segregation of 
the two cerebral hemispheres. Photoreceptors are among one of the 
most active organs in  Drosophila, and mutations in sphingolipid met-
abolic enzymes, especially  cdase 1 , show degeneration of photore-
ceptors. Examination of 10-d-old  bwa mutant fl ies showed no obvi-
ous degeneration of the photoreceptors as seen in  Figure 3B , 
indicating no endogenous function for the protein in maintaining 
photoreceptor homeostasis. Control  w 1118 and  bwa mutant head ex-
tracts show no difference in the steady-state levels of Rh1, Arr1, Arr2, 
INAD, NORPA, or G α , when examined by Western blot analysis 
( Figure 3C ). 
 The human alkaline ceramidase homologue has been reported to 
have robust ceramidase activity ( Mao  et al. , 2000a , 2000b, 2001, 
2003;  Xu  et al. , 2006 ; Mao and Obeid,  2008 ), thus we assessed the 
 bwa mutants for loss of ceramidase activity.  w 1118 was used as a wild-
type control, and the activity was compared against viable null 
 cdase 1 , the null mutant of CDase. As seen in  Figure 3D , extracts 
prepared from  bwa mutant did not demonstrate loss of ceramidase 
activity compared to  w 1118 extracts from pH 5.0 to 11.0. Viable null 
 cdase 1 mutant, in contrast, showed complete loss of ceramidase ac-
tivity ( Figure 1C ), indicating that CDase in  Drosophila contributes all 
observable enzymatic activity. The FlyBase records high levels of  Bwa 
transcript in the pupal stages of fl ies. Therefore we compared ce-
ramidase activity from pupal extracts of wild-type controls and  bwa 
and  cdase 1 mutants (Supplemental  Figure 1B ). Pupal extracts showed 
no loss of ceramidase activity in  bwa mutants, and all ceramidase 
activity could be ascribed to the CDase protein. We also tested the 
enzymatic activity of extracts from  w 1118 , viable null  cdase 1 , and  bwa 
for reverse ceramidase activity because alkaline ceramidases have 
as a mutant, and these fl ies were reported to exhibit fusion of the 
brain hemispheres. The fusion of the brain was not reliably seen in 
succeeding generations of the P-insertion fl ies and was therefore 
not a true phenotype ( Boquet  et al. , 2000 ; personal communica-
tion). The protein encoded by the  Bwa gene shows 46% identity 
and 70% similarity to the human alkaline ceramidase gene 1 
( Figure 2A ). We therefore expected BWA protein to demonstrate 
ceramidase activity as has been reported for members of the alka-
line ceramidase family ( Mao  et al. , 2001 ). Our initial analysis of the 
 cdase 1 mutant, however, failed to detect enzymatic activity that 
could be attributed to the putative alkaline ceramidase homologue, 
the  Bwa gene product. We therefore decided to investigate the role 
of BWA in ceramidase function in  Drosophila in greater detail. 
 Isolation of a bwa  null mutant 
 The  Bwa gene (CG13969) localizes to the left arm of the second 
chromosome at 38B2–3. The gene spans 7,356 nucleotides and 
contains four exons (392–529; 2679–2935; 3008–3145; and 5985–
6303). The transcript for the gene is expressed abundantly in most 
stages of development (except in the fi rst and early part of second 
instar larvae) and in the adults (FlyAtlas;  Chintapalli  et al. , 2007 ). 
A previously reported P-element is inserted in the second intron of 
the gene ( Boquet  et al. , 2000 ). Reverse transcription–PCR (RT–PCR) 
of the BWA gene product from these fl ies yielded full-length tran-
script, indicating that the P-insertion did not disrupt the gene. We 
mobilized this P-element and isolated two deletion alleles ( Figure 2B ). 
Both  bwa alleles delete exons 2 and 3. Whereas  bwa 1 deletes a 
2.358-kb fragment (between nucleotides 1352 and 3610 of the 
gene),  bwa 2 deletes a 2.282-kb fragment (between nucleotides 
1890 and 4182 of the gene). In both instances, RT–PCR sequencing 
of the truncated messenger RNAs revealed 
splicing of the fi rst exon to the fourth result-
ing in a truncated 47-amino-acid peptide. 
Thus both the alleles are null for BWA. The 
initial phenotypic characterization is re-
ported for both mutants, and all biochemi-
cal data are from the  bwa 1 allele. 
 bwa  mutants are viable and show no 
loss of ceramidase activity 
 Both  bwa mutant alleles resulted in viable 
and fertile fl ies that had a normal life span 
(Supplemental  Figure 1A ). Because the tran-
script levels are highest in the male acces-
sory gland, we compared the hatch rate of 
the mutant embryos to that of control  w 1118 
fl ies (in Day 3 and Day 10 fl ies ), to examine 
for fertility defects (FlyAtlas;  Chintapalli  et al. , 
2007 ). The hatch rate of the embryos from 
both mutant alleles was comparable to wild 
type at both ages. Also, ∼95% of  w 1118 em-
bryos reached adulthood, and ∼90% of  bwa 
mutant embryos eclosed as adults, indicat-
ing no signifi cant difference in the develop-
mental viability of these mutant fl ies. We also 
crossed both 3- and 10-d-old male and fe-
male  bwa mutant fl ies to control  w 1118 female 
and male fl ies, respectively. No differences in 
hatch rates of the embryos were observed in 
the progeny of these crosses. In addition, as 
can be seen in  Figure 3A , the cerebral hemi-
spheres appeared normal, and no fusion is 
 FIGURE 3:  Analysis of  bwa mutants. (A)  bwa null mutants do not display a defect in fusion of 
the central lobes of the brain. The control and the mutant lobes are both well developed and 
connected in the middle to other lobes in the developing third instar larvae. (B) Transmission 
electron micrograph (TEM) comparison of ommatidia from control  w 1118 and  bwa mutant show 
well-organized rhabdomeres and intact cellular morphology. (C) Phototransduction components 
are not affected in  bwa mutants as observed by Western analysis. 1-, 7-, 14-, and 21-d-old  w 1118 
and  bwa fl y head extracts were probed for the indicated proteins, and inositol polyphosphate 
1-phosphatase (IPP) was used as loading controls. (D) Extracts prepared from  bwa mutant 
display no loss of ceramidase activity across the pH range 5.0–11.0 compared to the control 
 w 1118 fl y extracts. (E) Extracts prepared from  bwa mutant fl ies show reverse ceramidase activity 
similar to extracts prepared from control  w 1118 fl ies at pH 5.0, 7.0, and 10.0, indicating no loss of 
reverse ceramidase activity in the mutant fl ies upon loss of BWA protein. 
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been proposed to be effi cient reverse ceramidases or acyl-coA–
independent ceramide synthases ( Mao  et al. , 2000a , 2000b). In assays 
performed to measure reverse ceramidase activity, we did not fi nd 
any difference in activity from control  w 1118 and  bwa mutants at pH 
5.0, 7.0, and 10.0, indicating that the BWA did not contribute to any 
measurable reverse ceramidase activity in  Drosophila ( Figure 3E ). 
 Sphingolipid profi le of  bwa mutant and overexpressors 
 To estimate the sphingolipid content of the control  w 1118 , bwa 
mutant, and control fl ies overexpressing the BWA protein, we used 
ultrafast liquid chromatography coupled with tandem mass spec-
trometry (UFLC MS/MS) (Table 1). The BWA protein that is overex-
pressed is functional because it rescues the lethality of the  cdase 1 
mutant and thus would provide the best control to evaluate the op-
posite effects of loss of BWA protein. As can be seen in  Figure 4, A–F , 
the loss of BWA protein results in accumulation of ceramide, cer-
amide phosphorylethanolamine (CPE) , ceramide 1-phosphate, glu-
cosylceramide, and lactosylceramide. We also observe a signifi cant 
reduction in sphingosine levels ( Figure 4B ). The increased ceramide 
and decreased sphingosine levels in the  bwa mutant could arise 
from a ceramidase-like function of BWA. If BWA were indeed a 
ceramidase, we would expect that the overexpressor fl ies would 
have lower levels of ceramide and a corresponding increase in 
sphingosine levels compared to controls. Our data reveal that BWA 
overexpressor extracts show little decrease in the steady-state lev-
els of ceramide. Instead, they show a substantial decrease in the 
levels of sphingosine, a fi nding not expected if BWA is a cerami-
dase ( Figure 4, A–F ). It is worth noting that sphingosine is not only 
generated by deacylation of ceramide to sphingosine by cerami-
dase, but is also an intermediate in the ceramide biosynthetic path-
way. The decreased sphingosine observed in the  bwa mutant could 
also result from increased conversion of the sphingosine generated 
in the  de novo biosynthetic pathway into other metabolites such as 
CPE, ceramide 1-phosphate, lactosylceramide, and glucosylcer-
amide. 
 In summary, extracts from  bwa mutants do not show decreased 
ceramidase activity, overexpression of BWA does not increase the 
ceramidase activity, and increased expression of BWA does not in-
crease the endogenous sphingosine levels. In  bwa mutants, we see 
a uniform increase in production of a number of metabolites, includ-
ing ceramide, CPE, ceramide 1-phosphate, glucosylceramide, and 
lactosylceramide. In contrast, overexpression of the protein does 
not greatly reduce the steady-state levels of any metabolites except 
sphingosine, the levels of which are decreased compared to those 
in wild type and  bwa mutants. Thus our data support the hypothesis 
that BWA is more a regulator of the fl ux through the sphingolipid 
biosynthetic pathway than is a ceramidase. 
 Genetic interaction of  Bwa with  CDase 
 Bwa encodes for a 283-amino-acid protein. We have failed to detect 
the endogenous BWA protein from wild-type controls in Western 
blots, and we have raised several antibodies against BWA. These 
antibodies failed to recognize an endogenous band at the appropri-
ate molecular weight on Western blots of wild-type controls that 
was missing in  bwa mutants. Our results indicated that either the 
protein was unstable or there was limited expression of the protein 
in these extracts. The latter scenario is unlikely, however, because a 
large amount of the transcript has been detected in head and intes-
tine of the fl ies. We therefore used a gain-of-function strategy to 
evaluate the protein function in vivo. We overexpressed BWA using 
the UAS-Gal4 system. This strategy enabled the production and de-
tection of substantially large amounts of the protein at the expected 
 Compound  Precursor  Product  CV  CE 
 Sphingosine   
 d14:1  244.2  208.2  15  15 
 d16:1  272.3  236.3  15  15 
 d17:1  286.3  268.2  15  15 
 Ceramide     
 d14:1/16:0  482.5  208.3  25  25 
 d14:1/18:1  508.5  208.3  30  25 
 d14:1/18:0  510.5  208.3  30  25 
 d14:1/20:0  538.5  208.3  35  30 
 d14:1/22:0  566.5  208.3  35  30 
 d14:1/24:1  592.6  208.3  40  30 
 d14:1/24:0  594.6  208.3  40  30 
 d16:1/14:0  482.5  236.3  25  25 
 d16:1/16:0  510.5  236.3  25  25 
 d16:1/18:0  538.5  236.3  30  25 
 d16:1/18:1  536.5  236.3  30  25 
 d16:1/20:0  566.5  236.3  35  30 
 d16:1/22:0  594.6  236.3  35  30 
 d16:1/24:0  622.6  236.3  40  30 
 d16:1/24:1  620.6  236.3  40  30 
 d18:1/12:0  482.6  264.2  25  25 
 d18:1/25:0  664.8  646.7  35  15 
 Ceramide 1-phosphate    
 d14:1/14:0  534.4  208.3  30  25 
 d14:1/16:0  562.4  208.3  30  25 
 d14:1/18:1  588.5  208.3  30  25 
 d14:1/18:0  590.5  208.3  30  25 
 d14:1/20:0  618.5  208.3  35  25 
 d14:1/22:0  646.5  208.3  35  30 
 d14:1/24:1  672.5  208.3  40  30 
 d14:1/24:0  674.5  208.3  40  30 
 d16:1/16:0  590.5  236.3  30  25 
 d16:1/18:0  618.5  236.3  30  25 
 d16:1/18:1  616.5  236.3  30  25 
 d16:1/20:0  646.5  236.3  30  25 
 d16:1/22:0  674.5  236.3  35  25 
 d16:1/24:0  702.6  236.3  35  30 
 d16:1/24:1  700.6  236.3  40  30 
 d18:1/12:0  562.5  264.5  30  25 
 Phosphoethanolamine ceramide   
 d14:1/18:0  633.5  208.3  35  30 
 d14:1/20:0  661.5  208.3  35  30 
 d16:1/18:0  661.5  236.3  35  30 
 d14:1/22:0  689.6  208.3  40  30 
 d16:1/20:0  689.6  236.3  35  30 
 d16:1/22:0  717.6  236.3  35  30 
 Glucosyl ceramide    
 d14:1/18:0  672.5  208.3  35  30 
 d14:1/20:0  700.6  208.3  35  30 
 d16:1/18:0  700.6  236.3  40  30 
 d14:1/22:0  728.6  208.3  40  30 
 d16:1/20:0  728.6  236.3  40  30 
 d16:1/22:0  756.6  236.3  40  30 
 d18:1/12:0  644.7  264.5  35  30 
 Lactosyl ceramide    
 d14:1/18:0  834.6  208.3  40  30 
 d14:1/20:0  862.6  208.3  40  30 
 d16:1/18:0  862.6  236.3  40  30 
 d14:1/22:0  890.7  208.3  40  30 
 d16:1/20:0  890.7  236.3  40  30 
 d16:1/22:0  918.7  236.3  45  30 
 d18:1/12:0  806.7  264.4  35  35 
 TABLE 1:  The conditions of SRM for the quantifi cation of sphingosine 
and ceramide species .
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molecular weight (∼30 kDa). The protein was visible on Western 
analysis of whole fl y extracts, when ubiquitously expressed using an 
Actin-Gal4 driver or in head extracts when BWA was expressed in 
the photoreceptors using Gmr-Gal4 (an eye-specifi c Gal4 driver). 
We examined tissue extracts from BWA overexpressor fl ies for ad-
ditional or new ceramidase activity as compared to wild-type control 
fl ies. As can be seen in  Figure 5A , targeted overexpression of BWA 
in  w 1118 controls exhibited the same level of activity as control  w 1118 
fl ies that were not expressing the protein . In fact, overexpression of 
the BWA protein does not show an increase in ceramidase activity 
over the entire pH range from 5.0 to 11.0. These results indicate 
that BWA protein exhibited no demonstrable ceramidase activity 
in  Drosophila tissue extracts. The extracts from these fl ies were 
also compared for reverse ceramidase activity, and no difference 
was observed (unpublished data ). 
 FIGURE 5:  Bwa genetically interacts with other ceramide-
metabolizing fl ies. (A) BWA overexpressor fl ies do not show an 
increase in ceramidase activity at any of the pH over the range 
5.0–11.0 when expressed in  w 1118 control background. Alternatively, 
 cdase 1 lethal mutants rescued by overexpression of BWA show no 
activity in any of the pH over the range 5.0–11.0. The experiments 
described here and in  Figure 3C were all done together. Thus the 
 w 1118 activities are the same. All activity measurements are an 
average of at least six measurements, and the error bars denote 
SD. (B) Genetic interactions of  bwa mutants and BWA 
overexpressors with CDase and DCERK.  bwa and viable null  cdase 1 
allele (denoted here as  suppressor ,  cdase 1 , for clarity) are 
individually viable, but the  bwa ; viable  cdase 1 ( suppressor ,  cdase 1 ) 
mutants are homozygous lethal. Similarly,  dcerk 1 is viable; however, 
 bwa ;  dcerk 1 double mutants are homozygous lethal. The  cdase 1 
allele in the absence of the suppressor mutation is homozygous 
lethal or lethal over a defi ciency. Overexpression of BWA in this 
background rescues the lethality of  cdase 1 . (C)  dcerk 1 mutants show 
an enormous increase in the level and stabilization of BWA protein in 
their extracts. The fi rst lane contains extracts from BWA 
overexpressor, the second lane from  dcerk 1 mutant, and the third 
lane from the  bwa mutant. Equivalent extracts were probed for 
DCERK, BWA, and also for IPP as loading control. As can be 
observed, there is increased production/stabilization of BWA protein 
in  dcerk 1 mutant. The faint band seen in  bwa mutant extract probed 
for BWA is a nonspecifi c band. 
 FIGURE 4:  bwa mutants show a general increase in levels of 
sphingolipid metabolites. (A) Mutant extracts show an approximate 
twofold increase in ceramide, and the overexpressor extracts do not 
show a decrease in ceramide levels compared to extracts prepared 
from control  w 1118  fl ies. (B) Lipid extracts prepared from mutant fl ies 
show a twofold decrease in sphingosine compared to control, but 
overexpressor fl ies show a further decrease in the levels of 
sphingosine. (C) Mutants show a near twofold increase in the steady-
state levels of CPE, whereas the overexpressors show a marginal 
decrease. (D) Ceramide 1-phosphate (Cer 1P) levels are slightly 
increased in the mutants and not changed in the overexpressors. 
(E) Glucosylceramide is increased in the mutant by approximately 
twofold and minimally affected in the overexpressor fl ies compared to 
the control. (F) Lactosylceramide is increased in the mutant animals and 
not substantially changed in the overexpressor fl ies. 
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 Because the  bwa mutants were viable and fertile and show no 
other obvious phenotype or compromise in basic function, we 
probed for genetic links between  Bwa and other genes the prod-
ucts of which act on ceramide in  Drosophila . Extracts from  bwa 
mutants show an increase in the level of ceramide and other 
sphingolipids and thus might show epistatic interaction with other 
ceramide-metabolizing enzymes. CDase converts ceramide to 
sphingosine, and  Drosophila ceramide kinase (DCERK) converts 
ceramide to ceramide kinase. We have generated null mutants for 
CDase ( cdase 1 ) and a severely hypomorphic allele for ceramide 
kinase ( dcerk 1 ).  cdase 1 mutants in isolation are homozygous le-
thal, and  dcerk 1 mutants are viable but have destabilization of 
NORPA (eye-specifi c phospholipase C) in photoreceptors, and 
retinal cells undergo degeneration ( Acharya  et al. , 2008 ;  Dasgupta 
 et al. , 2009 ). We undertook genetic interaction studies of  Bwa 
with these two genes because both mutants result in accumula-
tion of ceramide. As described earlier, a closely linked unknown 
suppressor mutation allowed us to recover viable null mutants of 
 cdase 1 over a defi ciency that uncovers this region ( Figure 5B ). 
When the EMS-mutagenized chromosome was backcrossed to 
wild-type chromosomes to get rid of the suppressor and other 
incidental mutations (this process is necessary to outcross all other 
mutations induced by EMS treatment of the chromosome), then 
 cdase 1 was homozygous lethal and lethal over the defi ciency. We 
used both these mutant  cdase “alleles” in our genetic interaction 
studies with  bwa mutants. We fi rst tested the effect of  bwa null 
allele in the viable  suppressor ,  cdase 1 /defi ciency (viable null) com-
bination. We failed to recover any viable progeny that was ho-
mozygous for  bwa 1 and  suppressor ,  cdase 1 /defi ciency ( Figure 5B ). 
Thus the double mutants of  bwa 1 ;  suppressor ,  cdase 1 /defi ciency 
was lethal even in the presence of the suppressor mutation. This 
result implied a genetic interaction between  Bwa and  CDase . 
Thus BWA was playing an essential role in the survival of cerami-
dase mutant fl ies in the suppressor genetic background. In paral-
lel experiments, we also expressed BWA ubiquitously using an 
Act-Gal4 (Gal4 driven under the control of the actin promoter). 
The overexpression of BWA was suffi cient to render even the 
lethal version (cleaned) of  cdase 1 viable. Thus targeted overex-
pression of BWA was capable of rescuing the lethality of  cdase 1 
mutant. These experiments suggest a strong genetic interaction 
between  Bwa and  CDase and implicate them in essential overlap-
ping functions in the fl y. 
 Ceramide kinase converts ceramide to ceramide 1-phosphate. 
We had recently shown that ceramide kinase mutant  dcerk 1 accu-
mulated ceramide. We therefore decided to test whether  Bwa ge-
netically interacted with ceramide kinase mutants.  dcerk 1 is a se-
verely hypomorphic mutant of DCERK. It was generated by the 
mobilization of a P-element situated in the promoter region of the 
 DCERK gene ( Dasgupta  et al. , 2009 ). These mutants are viable and 
have decreased fertility, but they can be maintained as a homozy-
gous stock at room temperature. Introduction of  bwa mutant allele 
into the  dcerk 1 mutants results in lethality ( Figure 5B ). Thus  bwa ; 
 dcerk 1  fail to develop into adult fl ies, indicating a requirement for 
BWA protein in the survival of  dcerk 1 mutant fl ies. We also observed 
that BWA protein, which we fail to observe in wild type and other 
backgrounds, is greatly stabilized and increased in the  dcerk 1 single 
mutant fl ies to levels attained in the photoreceptors of fl ies express-
ing Gmr-Gal4–driven UAS- Bwa ( Figure 5C ). 
 These studies indicate a strong genetic interaction among  Bwa, 
CDase, and  DCERK, and the gain-of-function studies also indicate 
that transgenic overexpression of BWA results in a functional pro-
tein. The rescue of  cdase 1 lethality provided us with a genetic back-
ground to investigate the biochemical activity of BWA in a back-
ground bereft of the predominant source of ceramidase activity. We 
therefore performed ceramidase assay from pH 5.0 to 11.0 in cdase 1 
mutants rescued by BWA overexpression to see whether we could 
observe an increased activity over the background observed in 
 cdase 1 viable null mutants. As can be seen in  Figure 5A , we did not 
see any activity across the entire pH spectrum. 
 It was earlier reported that human alkaline ceramidase homo-
logues exhibit ceramidase activity but preferred specifi c substrates, 
such as long-chain ceramides (D-erythro-C24 ceramide ), phytocer-
amide, or dihydroceramide ( Mao  et al. , 2000a , 2000b, 2001, 2003; 
 Xu  et al. , 2006 ; Mao and Obeid,  2008 ). We therefore tested cerami-
dase activity using each of these substrates in extracts prepared 
from  w 1118 , viable null  cdase 1 mutants, and  cdase 1 lethal rescued by 
BWA overexpression.  Figure 6A shows ceramidase activity mea-
sured at pH 5.0, 7.0, and 10.0 using d-erythro-C24 ceramide as the 
substrate; in these assays, only wild-type extracts containing CDase 
enzyme shows activity. Thus CDase contributes to all observable 
activity on long-chain ceramide. To rule out the requirements for 
specifi c lipid-based endogenous cofactors for BWA ceramidase ac-
tivity, we provided the substrate ceramides in liposomes prepared 
from lipid extracts of wild-type fl ies (instead of detergent-based 
substrate delivery). We performed activity measurements under 
these conditions in control  w 1118 ,  cdase 1 viable null mutant, and 
 cdase 1 lethal mutant rescued by BWA overexpressor fl ies at pH 5.0, 
7.0, and 10.0. Only control  w 1118 extracts displayed activity under 
these conditions (unpublished data ), ruling out lipid-specifi c cofac-
tor requirement for ceramidase activity for BWA protein.  Figure 6, B 
and C , shows ceramidase activity against 6-((N-(7-nitrobenz-2-
oxa-1,3-diazol-4-yl)amino) hexanoyl)sphingosine (NDB) -dihydrocer-
amide and NBD-phytoceramide. Here again NBD fatty acid genera-
tion or phytoceramidase and dihydroceramidase activity is exhibited 
only by extracts containing CDase and not in BWA overexpressors. 
(Extracts from  w 1118 and  bwa showed similar activity in using this 
substrate at pH 5.0, 7.0, and 10.0, indicating that BWA protein did 
not contribute to any of the ceramidase activity exhibited against this 
substrate by  Drosophila extracts; see  Figure 3E .) 
 In an attempt to evaluate whether the BWA protein could com-
plement the defects of ceramidase activity in yeast, we expressed 
BWA protein in yeast mutant for either YPC1 or the YDC1 gene 
product (Supplemental  Figure 2A ).  Δydc1 mutants are thermolabile 
( Mao  et al. , 2000b ). Expression of BWA did not rescue the heat sus-
ceptibility of  Δydc1 (Supplemental  Figure 2B ) or alter the fl ux 
through the sphingolipid biosynthetic pathway (Supplemental  Fig-
ure 2C ). These experiments indicate that the Drosophila BWA pro-
tein, unlike the mammalian or the yeast protein, does not possess 
ceramidase activity. It is also noteworthy that although BWA has 
profound infl uence on sphingolipid fl ux in  Drosophila, it is unable to 
affect the metabolic pathway in yeast. 
 DISCUSSION 
 Our studies indicate that the neutral ceramidase homologue, CDase, 
is the only functional ceramidase present in  Drosophila . Enzyme ac-
tivity studies demonstrate robust ceramidase activity in the pH range 
5.0–11.0 in  Drosophila extracts. All of this activity is lost in extracts of 
viable null mutant of CDase. Only one other homologue of a puta-
tive alkaline ceramidase is encoded by the genome and is named 
Brainwashing. Previously, in a screen designed to identify mutations 
in the development and organization of  Drosophila brain, the Preat 
laboratory had identifi ed a P-element insertion into the second 
intron of CG13969 ( Boquet  et al. , 2000 ). The authors initially noted 
that these fl ies had defective fusion of the cerebral hemispheres. 
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This phenotype was not penetrant, however, 
in subsequent generations of the fl ies and 
did not segregate with the P-insertion. Thus 
this phenotype was caused by an unlinked 
secondary mutation in the fl y and not by dis-
ruption of the CG13969 . We used this inser-
tion to generate deletion alleles of  Bwa in the 
current study. These mutants do not have de-
fects in hemisphere fusion. We could not fi nd 
any observable phenotype in these mutant 
animals. 
Recently it was reported that mutations in 
the  bwa gene, termed as  Dacer by the au-
thors in that study, resulted in increased lon-
gevity of the mutant fl ies ( Yang  et al. , 2010 ). 
It should be noted in the study that the au-
thors have used a P-element insertion in the 
fourth exon of the gene as the mutagen. Nei-
ther were rescue experiments performed nor 
was the P-element mobilized to generate de-
fi ned deletion mutants. In our studies, mere 
insertion of the P-element does not abrogate 
the ability to generate transcripts of the 
gene. We have shown that the insertion of 
P-element in the second intron of  Bwa did 
not affect the transcription of the gene. Our 
deletion mutants do not exhibit increased 
longevity or life span (Supplemental  Figure 
1A ). Also in the study by Yang et al., BWA 
protein was expressed in Sf9 cells, and the 
activity was measured from microsomal 
preparations. Those measurements were 
taken in the background of endogenous pro-
teins from Sf2 cells. The viable  cdase 1 null 
background shows no endogenous cerami-
dase activity, and in this background endog-
enous or overexpressed functional BWA ex-
hibits no ceramidase activity. We have also 
expressed BWA in S2 cells and partially puri-
fi ed it using affi nity chromatography. The 
partially purifi ed protein has also been tested 
for enzymatic activity and exhibits no cerami-
dase function (Supplemental  Figure 3, A–C ). 
Like the mammalian and the yeast homo-
logues, the protein shows a reticular pattern 
of expression overlapping with the ER-Golgi 
markers (Supplemental  Figure 3D ). Over-
whelming evidence from our group indicates 
that the  Drosophila BWA protein is not a ce-
ramidase but is a regulator of the ceramide 
fl ux within the  Drosophila . Mao and col-
leagues have extensively reported on the 
yeast alkaline ceramidase and the mamma-
lian homologues ACER1–3 ( Mao  et al. , 
2000a , 2000b, 2001, 2003;  Xu  et al. , 2006 ; 
Mao and Obeid,  2008 ). The proteins catalyze 
ceramidase reactions. 
In reconciling the present study with their 
extensive work with the yeast and mamma-
lian enzymes it is possible that BWA protein 
started out as a ceramidase and has gener-
ally retained this activity across species and 
 FIGURE 6:  BWA overexpressor fl ies show no ceramidase activity. (A) Extracts from 
control  w 1118 , viable null  cdase 1 ( cdase 1 null with the suppressor mutation), and BWA 
overexpressors in  w 1118 (BWA OE), and extracts from  cdase 1 null lethal fl ies that were 
rescued by BWA overexpression (BWA OE;  cdase 1 ) fl ies, were assayed for activity 
using a long-chain ceramide (D-erythro C-24 ceramide) as substrate. Control  w 1118 and 
 w 1118 overexpressing extracts show the same specifi c ceramidase activity against the 
long-chain ceramide, implying that BWA overexpression does not contribute to any 
observable increase in ceramidase activity at any of the three pHs indicated. Similarly, 
the viable allele of  cdase 1 and the lethal mutant of  cdase 1 rescued by overexpression 
of BWA show no activity when the assay is performed at the three pHs indicated. Thus BWA 
protein that is genetically active exhibits no biochemical ceramidase activity. All activity 
measurements are an average of at least six measurements, and the error bars denote SD. 
(B) Control extract is able to deacylate NBD-dihydroceramide, and this activity is lost in 
viable allele of  cdase 1 . The activity is not recovered in lethal mutants of  cdase 1 rescued by 
overexpression of BWA. (C) Control extract is able to deacylate NBD-phytoceramide, and 
this activity is lost in viable allele of  cdase 1 (suppressor, cdase 1 ) . The activity is not 
recovered in lethal mutants of  cdase 1 rescued by overexpression of BWA. 
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rated the solvent (the [ 3 H]C 16 - or C 24 -ceramide was obtained from 
the lipidomics shared resources, Medical University of South Car-
olina, Charleston, SC ). The residue was resuspended in 100 µl of 
100 mM buffer (NaOAc, pH 4.0–6.0; HEPES, pH 6.5–8.5; glycine, 
pH 9.0–11.0; Na 2 HPO 4 , pH 11.5–12.5) containing 0.2% Triton 
X-100 and 5 mM CaCl 2 . The reaction was initiated by the addition 
of ∼10 µg of total protein and was incubated for 1–2 h at 37°C. 
( Drosophila extracts are prepared by homogenization in the cor-
responding buffer containing protease inhibitors. The lysate is 
spun at 5000 ×  g for 10 min at 4°C. The supernatant is collected, 
and the protein concentration is determined.) The reaction was 
terminated by the addition of 2 ml of isopropyl alcohol/heptane/2N 
NaOH (78:20:2). Cold palmitic acid (50 µg) was added as carrier 
lipid, and phase partitioning was induced by the addition of 1.2 ml 
of heptane and 1 ml of water. After centrifugation, the upper 
phase was discarded. The lower phase was washed with two 1-ml 
aliquots of heptane, and the upper phase was discarded after 
each centrifugation. The lower phase was acidifi ed with 1 ml of 
1N H 2 SO 4 to protonate the released fatty acid. Heptane (2 ml) 
was added, vortexed, and centrifuged, and 1.5 ml of the upper 
phase was transferred to a scintillation vial and counted. The 
activity was calculated. Most assays were done in duplicate and 
repeated at least three times. 
 It is possible that BWA activity requires cofactors that might not 
be supplied in the regular assay. To verify this possibility, we de-
signed an assay in which the substrate (ceramide) was provided in 
liposomes prepared from  Drosophila total lipid extract. Briefl y, 
10–15 fl ies were washed with phosphate-buffered saline (PBS) 
three times and homogenized in the assay buffer. The homoge-
nate was mixed with equal volumes of chloroform methanol (2:1) 
and vortexed. The organic phase was collected and evaporated 
under nitrogen. Radiolabeled ceramide was added to the total 
lipid extract and suspended in assay buffer. This suspension was 
sonicated in a water bath sonicator to prepare liposomes. These 
liposomes were used as substrate for the ceramidase assay as 
described earlier in this article. 
 Reverse ceramidase assay 
 The assay was performed as described with slight modifi cations (El 
 Bawab  et al. , 2001 ). Briefl y, the substrates ([ 3 H]palmitic acid, cold 
palmitic acid, and sphingosine) were dried and then resuspended in 
100 µl of 100 mM buffer (NaOAc, pH 5.0; HEPES, pH 7.0; glycine, 
pH 10.0), containing 0.2% Triton X-100; 20 µg of fl y total protein was 
used for each reverse action. The enzymatic reaction was carried out 
at 37°C for 1–2 h. The reaction was terminated by adding 2 ml of 
isopropyl alcohol/heptane/2N NaOH (78:20:2), followed by 1 ml of 
water and 1 ml of heptane. The upper phase was collected after 
centrifugation. The lower phase was washed with 2 ml of heptane, 
and the upper phase was collected again and counted in a scintilla-
tion counter. Most assays were done in duplicate and repeated 
three times. 
 Expression and purifi cation of bwa protein in S2 cells 
 Drosophila Bwa was cloned into pRmHa-C vector in frame with the 
Flag and Histidine tag and expressed in S2 cells using standard 
techniques. Protein expression in these stable cell lines was induced 
by adding copper sulfate (0.5 mM) to the medium . The cells were 
washed and lysed in 20 mM sodium phosphate buffer, pH 7.4, con-
taining protease inhibitors. Nuclei and other cellular debris were 
removed by low-speed centrifugation. A membrane pellet was pre-
pared from the supernatant by ultracentrifugation at 110,000 ×  g 
for 1 h. 
kingdom. In certain clades (perhaps) or special circumstances, such 
as in  Drosophila melanogaster, however, the protein lost its cerami-
dase activity and in its place acquired a role of monitoring ceramide 
levels. Further studies in this regard should resolve this matter. An 
example of such a change is seen in the human caspase-12 gene. 
Eighty percent of humans do not encode for a functional caspase-12 
gene ( Fischer  et al. , 2002 ;  Kachapati  et al. , 2006 ;  Xue  et al. , 2006 ). 
In these human populations, and unlike in mouse and chimpanzees, 
the caspase-12 gene has accumulated several mutations rendering 
it inactive as a caspase protein; hence, it is not involved in ER-
mediated apoptosis. It is now believed that caspase-12 gene prod-
uct is involved in mediating the ill effects of sepsis and is one of the 
major causes of mortality in children across the world. The pressures 
to avoid sepsis and to survive are believed to be strong selective 
forces in the spread of the inactive form of caspase-12 in humans. 
 A search of the motifs present in the BWA protein using the 
PRINTS program ( http://www.bioinf.manchester.ac.uk/fi ngerPRINT
Scan/ ) indicates that the protein demonstrates motifs with some 
similarity to those present in channels, bacterial transporters , and 
translocase proteins ( Attwood  et al ., 2004 ). Thus BWA might func-
tion to assist the movement of ceramides in the membrane environ-
ment, and perhaps even regulate the sphingolipid metabolic path-
way by facilitating easier movement of ceramides across layers 
of membranes in its vicinity. Increased mobility might in turn im-
prove the accessibility of ceramide to other enzymes that act on 
ceramide, thereby expediting its metabolism. It is worth noting that, 
although the  bwa mutant accumulates amounts of ceramide similar 
to those in  cdase 1 and  dcerk 1 mutants, it exhibits neither the lethal-
ity observed in the former nor the retinal degeneration observed in 
the latter. Because each of these enzymes localizes to different com-
partments of the cell, the pool of ceramides that is at least initially 
affected in each of these mutant backgrounds will be different. 
Therefore the effect of ceramide accumulation in each one of these 
mutants will depend on the physiological function affected by such 
ceramide accumulation. Accumulation in  cdase 1 mutants in the 
outer leafl et and the endolysosomal compartment is detrimental to 
synaptic signaling in  cdase mutants and thus they are embryonic 
lethal ( Rohrbough  et al. , 2004 ;  Acharya  et al. , 2008 ). Accumulation 
of similar levels of ceramide initiated in the inner membrane of cer-
amide kinase mutants is detrimental to photoreceptor structure and 
function but does not compromise embryonic synaptic signaling as 
to cause death ( Dasgupta  et al. , 2009 ). In the case of  bwa mutants, 
the accumulation of ceramide (perhaps in other inner membrane 
compartments) does not affect the development or phototransduc-
tion in  Drosophila . Thus context-dependent ceramide accumulation 
is critical for the observed phenotypes. 
 Thus our experiments demonstrate that all observable cerami-
dase activity in  Drosophila is contributed by CDase protein and no 
activity is attributable to BWA. Yet we see a strong genetic interac-
tion of  Bwa with genes for two of the enzymes that function to re-
duce ceramide levels  in vivo . These studies imply that BWA either 
exhibits ceramidase activity that is activated only under specifi c cir-
cumstances or could have an as yet unknown biochemical function 
that would effectively decrease ceramide levels  in vivo without bio-
chemical activity as a ceramidase. 
 MATERIALS AND METHODS 
 Ceramidase assay 
 The assay was performed as described previously with slight 
modifi cations (Dobrowsky and Kolesnick,  2001 ). Briefl y, [ 3 H]C 16 - 
or C 24 -ceramide and cold C 16 - or C 24 -ceramide in chloroform/
methanol (2:1 vol/vol ) were added to each assay tube and evapo-
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formic acid (solvent B) with a fl ow rate of 0.3 ml/min. The column 
was eluted with isocratic elution 20% of solvent A for 5 min, fol-
lowed by a linear gradient from 80% to 99% solvent B in 6 min. The 
column temperature was 60°C. 
 Mass spectrometric detection was carried out on a TQD mass 
spectrometer (Waters Co.) with the electrospray ionization (ESI) 
source set in positive mode . Quantifi cation was performed using 
selected reaction monitoring (SRM) of the transitions with a 
can time of 0.014−0.036 s per transition. Parameters used are 
as follows: capillary voltage 2.0 kV, source temperature 120°C, 
desolvation temperature 450°C. Nitrogen was used as for 
desolvation and as cone gas with fl ow rates of 1000 and 50 l/h, 
respectively. 
 Expression of  Drosophila bwa protein in the yeast 
 Δypc1 ,  Δydc1, and wild-type Mat A type (BY4741)  Saccharomyces 
cerevisiae were obtained from Open Biosystems (Huntsville, AL) . 
Cloning and expression of  Drosophila Bwa gene was essentially 
similar to that described previously ( Mao  et al. , 2001 ). Briefl y, the 
 Drosophila Bwa cDNA was cloned in to pYES2 vector in frame with 
the V5 tag. The three yeast strains were transformed with the con-
struct by using lithium acetate. The cells were plated on Synthetic 
Complete medium lacking uracil (SC –Ura) and incubated for 
2 d at 30°C. For the induction of the protein, the cells were grown 
in SC –Ura supplemented with 2% galactose for 4 h, and the 
protein expression was verifi ed by immunoblotting using anti-V5 
antibody. 
 Heat stress study 
 Exponentially growing cells (5.2 × 10 5 total in 100 µl) were incubated 
at room temperature (untreated) or at 45°C for 50 min (heat stress). 
The untreated cells were diluted 500 times, and 5 µl was plated on 
to Yeast Proteome Database (YPD) plates. For the heat-stressed 
cells, 10 µl was directly plated on the plates. The plates were incu-
bated at 30°C for 2 d, and the colonies were counted using a Bio-
Rad (Hercules, CA) gel documentation system. 
 Labeling of yeast cells 
 A single isolated yeast colony was inoculated into SC –Ura supple-
mented with 2% glucose and cultured overnight. The overnight 
culture was inoculated into 1 ml of fresh medium, and the cells 
were grown to an optical density of 0.6–0.7. The culture medium 
was then supplemented with 30 µCi of [ 3 H]palmitic acid, and the 
cells were further incubated at 30°C for an additional 4 h. Total 
lipids were extracted, deacylated by monomethylamine, and re-
solved by TLC by using the solvent system containing chloroform, 
methanol, and 4.2 N ammonium hydroxide in the ratio of 9:7:2. 
For the cells transfected with pYES2  Bwa construct, the medium 
contained galactose instead of glucose during the induction and 
labeling period. 
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 The membrane pellet was lysed in buffer A (5 mM imidazole, 
500 mM sodium chloride in 20 mM phosphate buffer) with 1% Triton 
X-100. BWA was purifi ed using nickel affi nity chromatography. 
Briefl y, the lysate was loaded on to a Histrap column equilibrated 
with buffer A, and the column was washed with 5 column volumes 
of the same buffer. The unbound proteins were washed off by in-
creasing the concentration of imidazole to 200 mM in buffer A . 
Finally the bound BWA protein was eluted with buffer B (400 mM 
imidazole, 500 mM sodium chloride in 20 mM phosphate buffer), 
and 200-µl fractions were collected. The fractions were tested on 
12% SDS–PAGE to check for purity. The fraction with the highest 
purity was used in the ceramidase assay. 
 Phytoceramidase and dihydroceramidase activities 
 The activity was measured using C 12 -NBD-phytoceramide or NBD-
C 12 -dihydroceramide (from Matreya, Pleasant Gap, PA) as sub-
strates. The solvent was evaporated and resuspended in 100 µl of 
100 mM buffer (NaOAc, pH 5.0; HEPES, pH 7.0; glycine, pH 10.0) 
containing 0.2% Triton X-100 and 2.5 mM CaCl 2 . After incubation 
at 37°C for 60 min, NBD-C 12 –fatty acid was released. The reac-
tions were stopped by boiling for 5 min and dried under a Speed-
Vac. Lipids were dissolved in 35 µl of chloroform/methanol (2:1), 
and 25 µl was spotted onto a thin-layer chromatography (TLC) 
plate. The released NBD-fatty acid was separated from NBD-
ceramide by TLC in a solvent of chloroform/methanol/25% am-
monium hydroxide (90:30:0.5). The TLC plate was scanned using a 
PhosphorImager system set at the fl uorescence mode. The NBD-
fatty acid product was identifi ed by comparison with NBD-C 12 
(Matreya, Pleasant Gap, PA). 
 Generation of  bwa mutants 
 The  bwa null deletion mutants were generated by mobilizing a P-
element described previously ( Boquet  et al. , 2000 ). The P-element 
was inserted into the second intron of  Bwa and was mobilized using 
standard P-element mutagenesis screen. Approximately 500 exci-
sion lines were generated and screened by PCR for potential dele-
tion alleles. Two lines,  bwa 1 and  bwa 2 , were identifi ed in the screen 
by genomic PCR, RT-PCR, and sequencing of the RT-PCR products. 
Oligos were used for genomic PCR of the two mutants:  bwa 1 –  for-
ward primer – ATACGCTCGCGATTTCATTT,  reverse primer – TC-
GAAACTGTCCCGAAAAAC;  bwa 2 –  forward primer – TCCCCAA-
CACGATGACAATA,  reverse primer – TGGCCACCGGTATAACACTT. 
For RT-PCR the following primers were used:  forward primer – 
CTAAGATTGCAAGGAAGGGCG,  reverse primer – TTTAGGCCCA-
AGTGTTCAGG. Both mutants had deletions that resulted in the 
generation of a truncated peptide containing 47 amino acids of the 
fi rst exon  MGGMGGGGLLDIYAMAWEHLRPGSSPVDWCEGNYLISS-
NIAEFVNTS stop. 
 Antibodies 
 Antibodies used in this study were raised using standard protocol in 
rabbit against the following peptide from the C terminus of the pro-
tein: C G I P F I S I R N P G K A L R N T I. 
 Sphingolipid measurements 
 Lipids were extracted from fl y heads following the protocol de-
scribed previously. Liquid chromatography was performed on an 
ACQUITY UPLC system (Waters Co., Milford, MA). The sphingoli-
pids were separated using an ACQUITY UPLC BEH Shield RP18 col-
umn (100 mm × 2.1 mm i.d.) maintained at 60°C. The mobile phase 
was composed of 5 mM HCOONH 4 in water containing 0.2% formic 
acid (solvent A) and 5 mM HCOONH 4 in methanol containing 0.2% 
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